Published in J Psychiatr Res on July 21, 1999
Exercise Training in Depressed Traumatic Brain Injury Survivors | NCT01805479
Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A (2000) 1.69
The CRF system mediates increased passive stress-coping behavior following the loss of a bonded partner in a monogamous rodent. Neuropsychopharmacology (2008) 1.47
CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol (2004) 1.44
Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study. Biol Psychiatry (2004) 1.39
Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology (2011) 1.27
Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl) (2005) 1.26
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov (2012) 1.22
Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol (2001) 1.19
Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. Am J Psychiatry (2005) 1.16
Neurobiology of stress-induced reproductive dysfunction in female macaques. Mol Neurobiol (2008) 1.14
The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest (2004) 1.14
Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction. Brain Res (2009) 1.10
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology (Berl) (2005) 1.04
Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proc Natl Acad Sci U S A (2005) 1.01
Genetic animal models of anxiety. Neurogenetics (2003) 1.00
The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain. Br J Pharmacol (2002) 0.98
Dose-dependent effects of endotoxin on neurobehavioral functions in humans. PLoS One (2011) 0.96
Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep. Mol Psychiatry (2009) 0.96
A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory. Neuropsychopharmacology (2011) 0.94
Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior. Alcohol (2012) 0.94
Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor. Bioorg Med Chem (2015) 0.91
Sex-biased stress signaling: the corticotropin-releasing factor receptor as a model. Mol Pharmacol (2012) 0.91
A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Transl Psychiatry (2011) 0.89
Genetic approach for intracerebroventricular delivery. Proc Natl Acad Sci U S A (2010) 0.88
Biomarkers predicting antidepressant treatment response: how can we advance the field? Dis Markers (2013) 0.86
Region-specific roles of the corticotropin-releasing factor-urocortin system in stress. Nat Rev Neurosci (2016) 0.85
Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Psychopharmacology (Berl) (2006) 0.84
Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity. J Chem Neuroanat (2011) 0.84
On the role of corticotropin-releasing hormone receptors in anxiety and depression. Dialogues Clin Neurosci (2002) 0.84
The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology (2012) 0.84
Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing mice. Cell Mol Neurobiol (2011) 0.84
Is it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health. Front Endocrinol (Lausanne) (2013) 0.83
Co-localization of corticotropin-releasing factor and vesicular glutamate transporters within axon terminals of the rat dorsal raphe nucleus. Brain Res (2007) 0.83
The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment. Psychoneuroendocrinology (2010) 0.83
Ovarian steroid regulation of the midbrain corticotropin releasing factor and urocortin systems in macaques. Neuroscience (2010) 0.83
Corticotropin releasing hormone receptor 2 (CRHR-2) gene is associated with decreased risk and severity of posttraumatic stress disorder in women. Depress Anxiety (2013) 0.82
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonist. Toxicology (2008) 0.82
PET Imaging of CRF1 with [11C]R121920 and [11C]DMP696: is the target of sufficient density? Nucl Med Biol (2007) 0.82
Overexpression of corticotropin-releasing factor in Barrington's nucleus neurons by adeno-associated viral transduction: effects on bladder function and behavior. Eur J Neurosci (2012) 0.80
Towards the clinical implementation of pharmacogenetics in bipolar disorder. BMC Med (2014) 0.80
Indirect effect of corticotropin-releasing hormone receptor 1 gene variation on negative emotionality and alcohol use via right ventrolateral prefrontal cortex. J Neurosci (2014) 0.79
Tianeptine: an antidepressant with memory-protective properties. Curr Neuropharmacol (2008) 0.79
Treatments in depression. Dialogues Clin Neurosci (2006) 0.79
Chronic Administration of Monosodium Glutamate under Chronic Variable Stress Impaired Hypothalamic-Pituitary-Adrenal Axis Function in Rats. Korean J Physiol Pharmacol (2010) 0.78
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM). Bioorg Med Chem (2008) 0.78
The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells. Psychopharmacology (Berl) (2013) 0.78
Hormone treatment of depression. Dialogues Clin Neurosci (2011) 0.77
The effect of long-term ovariectomy on midbrain stress systems in free ranging macaques. Brain Res (2012) 0.77
Using high resolution imaging to determine trafficking of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Life Sci (2014) 0.77
Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919). Psychopharmacology (Berl) (2005) 0.77
Deducing corticotropin-releasing hormone receptor type 1 signaling networks from gene expression data by usage of genetic algorithms and graphical Gaussian models. BMC Syst Biol (2010) 0.76
Stress-sensitive neurosignalling in depression: an integrated network biology approach to candidate gene selection for genetic association analysis. Ment Illn (2012) 0.76
Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors. Psychopharmacology (Berl) (2016) 0.76
Effects of fluoxetine on CRF and CRF1 expression in rats exposed to the learned helplessness paradigm. Psychopharmacology (Berl) (2012) 0.75
Emerging drugs for the treatment of anxiety. Expert Opin Emerg Drugs (2015) 0.75
Late-Onset Cognitive Impairments after Early-Life Stress Are Shaped by Inherited Differences in Stress Reactivity. Front Cell Neurosci (2017) 0.75
Redesigning antidepressant drug discovery. Dialogues Clin Neurosci (2014) 0.75
Synthesis and Biological Evaluation of New CRH Analogues. Bioinorg Chem Appl (2010) 0.75
Extrahypothalamic corticoliberin receptors regulate the reinforcing effects of self-stimulation. Dokl Biol Sci (2006) 0.75
Mirtazapine acutely inhibits basal and K(+)-stimulated release of corticotropin-releasing hormone from the rat hypothalamus via a non-genomic mechanism. Psychopharmacology (Berl) (2004) 0.75
The role of glucocorticoids and corticotropin-releasing hormone regulation on anxiety symptoms and response to treatment. Endocr Connect (2017) 0.75